Hainan Hailing

Hainan Hailing Chemipharma Co., Ltd. is a prominent Chinese pharmaceutical company and a key subsidiary of the Yangtze River Pharmaceutical Group. Established in 2004 and headquartered in Haikou, the company specializes in the research, development, and large-scale manufacturing of anti-infective medications, particularly cephalosporin antibiotics. Its flagship products, including Ceftazidime and Cefotaxime, have secured significant market share in China due to their high quality and clinical efficacy. The company operates advanced, GMP-certified production facilities that support a broad portfolio encompassing gastrointestinal and cardiovascular treatments. As a leading high-tech enterprise in the Hainan Free Trade Port, Hainan Hailing plays a vital role in the regional economy and the broader Chinese healthcare supply chain.